100X Gains On Tap as Under-the-Radar Green-Tech Stock Soars
Searching for the next 1,000% stock winner? Look no further than key Green-Techs that are driving the EV, Solar & 5G booms. Silver is the #1 element in the Green Energy Revolution & we’ve found the top silver gem – undiscovered at 10-cents per share – that’s fueling the path to a carbon-free world.
Get the details here...
pixel

PLXP Insider Trading (PLx Pharma)

Insider Ownership Percentage: 9.42%
Insider Buying (Last 12 Months): $1,242,329.50
Insider Selling (Last 12 Months): $0.00

PLx Pharma Insider Trading History Chart

PLx Pharma Share Price & Price History

$9.56
▲ +0.56 (6.22%)
As of 04/9/2021 01:00 AM ET
Days: 30 | 90 | 365
Learn How to Analyze Your Market and Trading Plan
Custom-design an options strategy to fit your market outlook. This guide goes beyond the basics to help you understand how to evaluate a strategy’s risk and reward. Start with your market outlook, then hone in on your strategy based on the risk you’re willing to take.
Download Your FREE Options Trading Strategy Guide today!
pixel

PLx Pharma Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/5/2021Michael J ValentinoChairmanBuy25,000$8.00$200,000.00486,690  
12/14/2020John HaddenDirectorBuy1,000$5.45$5,450.003,290  
11/18/2020Michael J ValentinoChairmanBuy264,900$3.79$1,003,971.00461,690  
9/1/2020Rita M O'connorCFOBuy4,500$3.74$16,830.0010,850  
8/21/2020Rita M O'connorCFOBuy4,050$3.97$16,078.502,300  
5/20/2019Michael J ValentinoInsiderBuy44,404$5.60$248,662.40  
12/27/2018Park West Asset Management LlcMajor ShareholderBuy397,495$1.00$397,495.00  
See Full Table

SEC Filings (Institutional Ownership Changes) for PLx Pharma (NASDAQ:PLXP)

22.46% of PLx Pharma stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

PLx Pharma Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in Company
2/12/2021Credit Suisse AG27,394$0.15M0.0%N/A0.299%
2/10/2021Renaissance Technologies LLC139,083$0.77M0.0%+79.0%1.519%
4/15/2020Heritage Way Advisors LLC41,712$94K0.1%+31.5%0.456%
2/10/2020University of Texas Texas AM Investment Managment Co.62,673$0.27M0.3%N/A0.685%
11/27/2019Millennium Management LLC51,963$0.27M0.0%-32.1%0.568%
10/30/2019Heritage Way Advisors LLC30,000$0.15M0.1%N/A0.332%
8/14/2019Vanguard Group Inc.145,649$1.05M0.0%+29.2%1.642%
8/13/2019BlackRock Inc.9,897$72K0.0%+150.1%0.112%
8/12/2019Renaissance Technologies LLC64,711$0.47M0.0%+10.4%0.729%
6/30/2019Nottingham Advisors Inc.58,584$0.42M0.1%N/A0.660%
2/15/2019Millennium Management LLC57,213$88K0.0%-33.6%0.654%
2/14/2019Park West Asset Management LLC1,473,218$2.25M0.1%+37.0%16.839%
1/29/2019Harel Insurance Investments & Financial Services Ltd.250,000$0.38M0.0%-54.5%2.857%
12/13/2018Vanguard Group Inc163,431$0.66M0.0%+98.0%1.870%
11/23/2018Vanguard Group Inc.163,431$0.66M0.0%+98.0%1.870%
6/28/2018Brown Advisory Inc.75,000$0.25M0.0%-31.8%0.859%
5/15/2018CVI Holdings LLC46,096$0.15M0.2%N/A0.528%
5/2/2018Texas Treasury Safekeeping Trust Co.58,567$0.20M0.0%N/A0.671%
2/15/2018683 Capital Management LLC124,557$0.86M0.1%-50.0%1.428%
2/13/2018Renaissance Technologies LLC32,512$0.22M0.0%+44.4%0.373%
2/12/2018Brown Advisory Inc.110,000$0.76M0.0%N/A1.261%
2/1/2018Harel Insurance Investments & Financial Services Ltd.550,000$0.36M0.0%+120.0%6.307%
12/7/2017683 Capital Management LLC249,300$1.60M0.2%-14.3%2.859%
11/20/2017Susquehanna International Group LLP151,900$0.99M0.0%-33.9%1.742%
11/2/2017Harel Insurance Investments & Financial Services Ltd.250,000$0.15M0.0%N/A2.878%
8/15/2017Susquehanna International Group LLP229,800$1.41M0.0%N/A5.243%
8/3/2017University of Texas Investment Managment Co.62,673$0.39M1.1%N/A1.430%
7/18/2017Heritage Way Advisors LLC32,101$0.20M0.2%N/A0.370%
Data available starting January 2016

See Full Table
PLx Pharma logo
PLx Pharma Inc., a late-stage specialty pharmaceutical company, focuses on developing the PLxGuard delivery system to provide various products in the United States. The company's lead product candidates are Vazalore 325 mg and Vazalore 81 mg, which are formulations of aspirin that use the PLxGuard delivery system to reduce novel gastrointestinal (GI) side effects while providing antiplatelet effectiveness for cardiovascular disease prevention and treatment. Its product pipeline also includes other oral nonsteroidal anti-inflammatory drugs using the PLxGuard delivery system, such as PL1200 Ibuprofen 200 mg, a GI-safer ibuprofen product for pain and inflammation, as well as PL1100 Ibuprofen 400 mg. PLx Pharma Inc. was founded in 2002 and is headquartered in Sparta, New Jersey.
Read More

Today's Range

Now: $9.56
$9.25
$10.20

50 Day Range

MA: $8.45
$7.00
$10.14

52 Week Range

Now: $9.56
$2.28
$10.40

Volume

325,635 shs

Average Volume

289,145 shs

Market Capitalization

$208.28 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

5.03

Who are the company insiders with the largest holdings of PLx Pharma?

PLx Pharma's top insider shareholders include:
  1. Michael J Valentino (Chairman)
  2. Rita M O'connor (CFO)
  3. John Hadden (Director)
  4. Michael J Valentino (Insider)
100X Gains On Tap as Under-the-Radar Green-Tech Stock Soars
Searching for the next 1,000% stock winner? Look no further than key Green-Techs that are driving the EV, Solar & 5G booms. Silver is the #1 element in the Green Energy Revolution & we’ve found the top silver gem – undiscovered at 10-cents per share – that’s fueling the path to a carbon-free world.
Get the details here...
pixel